Max Healthcare Institute Limited (BOM:543220)

Max Healthcare Institute Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	14,424	10,759	10,576	11,035	6,051
Depreciation & Amortization	4,381	3,519	2,379	2,252	2,138
Other Amortization	83.9	75	70.6	69.5	73
Loss (Gain) From Sale of Assets	-6.5	-1.1	-4.5	-13.3	30.6
Asset Writedown & Restructuring Costs	-	-	-	-	0.6
Stock-Based Compensation	483.3	545.9	496.2	343.6	339.3
Provision & Write-off of Bad Debts	471.6	250.6	109.8	74.1	92.4
Other Operating Activities	-877.8	478.1	-818.8	-2,477	-14
Change in Accounts Receivable	-3,231	-2,091	-1,087	647.4	29.1
Change in Inventory	-87.3	-192	59	-148.7	-75.6
Change in Accounts Payable	732.9	811.7	-402.6	987.3	-447.8
Change in Other Net Operating Assets	-41.2	224.1	-161.7	70.9	-811.1
Operating Cash Flow	16,333	14,380	11,217	12,841	7,405
Operating Cash Flow Growth	13.59%	28.20%	-12.65%	73.41%	528.31%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-14,845	-9,445	-7,860	-3,356	-5,533
Sale of Property, Plant & Equipment	160.5	64.1	63.4	39.2	51.7
Cash Acquisitions	-	-6,247	-6,300	-4.8	-1,072
Divestitures	406.6	-	-	-	-
Investment in Securities	-25.7	-7.7	-12.6	-	-1,712
Other Investing Activities	1,044	1,979	1,254	1,949	742.2
Investing Cash Flow	-16,890	-16,107	-12,855	-1,023	-7,638

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	284.5	23	141.5	-	202.8
Long-Term Debt Issued	5,393	13,472	6,279	70.7	365.6
Total Debt Issued	5,677	13,495	6,420	70.7	568.4
Short-Term Debt Repaid	-	-	-	-289.5	-
Long-Term Debt Repaid	-1,699	-12,273	-6,223	-1,967	-2,637
Total Debt Repaid	-1,699	-12,273	-6,223	-2,257	-2,637
Net Debt Issued (Repaid)	3,978	1,222	197.6	-2,186	-2,069
Issuance of Common Stock	338.2	2.3	9.9	13.1	36.6
Common Dividends Paid	-1,456	-1,456	-970.1	-	-
Other Financing Activities	-2,268	-1,400	-1,875	-712.7	-909.5
Financing Cash Flow	592.7	-1,632	-2,637	-2,886	-2,942

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	6.2	1.2	-18.2	1.1	-
Miscellaneous Cash Flow Adjustments	-	175.1	347.2	-	-
Net Cash Flow	42.2	-3,183	-3,946	8,934	-3,175

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	1,488	4,935	3,357	9,485	1,872
Free Cash Flow Growth	-69.85%	46.99%	-64.61%	406.74%	-
Free Cash Flow Margin	1.78%	7.02%	6.21%	20.79%	4.75%
Free Cash Flow Per Share	1.52	5.05	3.44	9.76	1.93
Levered Free Cash Flow	-2,247	5,519	2,974	7,946	655.69
Unlevered Free Cash Flow	-902.5	6,449	3,253	8,391	1,218

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	540.3	444.7	1,874	713.2	909.5
Cash Income Tax Paid	3,719	3,209	2,693	1,611	1,091
Change in Working Capital	-2,627	-1,247	-1,592	1,557	-1,305

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error